Earnings Watch: JP Morgan and Goldman Sachs among seven Dow components expected to report this week as earnings season revs into gear after two straight quarters of decline
Normally ‘something gives’ when the greenback gets this strong
IMF likely to lower global growth forecast further Tuesday
Two economists crunched the numbers on more than 70,000 lower-income households
Stocks surge in Hong Kong, mainland China; Nikkei closed
Wariness over the strength of an agreement hammered out between the U.S. and China last week was growing after a report that Beijing will insist on more talks with the U.S. before signing any such deal.
State of Michigan reportedly withdraws funds following furor over fund CEO’s sexist comments
Oil prices remain heavily influenced by demand concerns resulting from international trade uncertainty
Critical information for the U.S. trading day
Microsoft is now the major driver of S&P 500 gains
Edgewise’s stock jumps 50% on the back of safety data for potential heart disease rival to Camzyos
In 2 papers, researchers describe potential new neurodegenerative disease treatment approach
Aligos’ MASH prospect slashes liver fat in phase 2, but stock drops anyway
Vanda receives FDA rejection, issues fiery response against ‘conclusory’ refusal
Jury rules for Axonics in Medtronic’s long-running neuromodulation patent lawsuit
Achilles drops cell therapy program, braces for layoffs after missing ‘commercial viability’ goals
Basilea scores $268M BARDA funding deal to work on antifungals, antibiotics
From ‘science fiction to reality’: New George Church-founded biotech raises $75M for cell therapy platform
How the Stock Market Defied Expectations Again This Year, by the Numbers
US Applications for Unemployment Benefits Hold Steady, but Continuing Claims Rise to 3-Year High
